Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
110.50    -4.00 (-3.49%)
Bid:
107.00
Ask:
114.00
Spread: 7.00 (6.542%)
Market Cap: £14.90m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Half-Year Trading Update

17 Jul 2019 07:00

RNS Number : 7572F
Itaconix PLC
17 July 2019
 

 

17 July 2019

Itaconix plc ("Itaconix" or the "Company")

Half-Year Trading Update

Itaconix (AIM: ITX), a leading innovator in sustainable specialty polymers, is pleased to announce the following trading update for the six-month period ended 30 June 2019.

Demand for the Company's proprietary detergent, odour control and hair styling polymers continued to grow from steady penetration of their use as key functional ingredients in an increasing range of everyday consumer product formulations for home and personal care.

As a result, unaudited revenues for the first half of 2019 grew to £0.5 million, which reflects a 59% increase over the same period in 2018 and a 33% increase compared to the second half of 2018. First half revenues also represent 72% of revenues for the previous full year.

Unaudited EBITDA(1) was a loss of £1.0 million, compared to a loss of £2.4 million for the same period in 2018 and a loss of £1.4 million for the second half of 2018. These reduced losses reflect the success of the Company's efforts to reduce the overall cost base while growing revenues.

Net cash as at 30 June 2019 was £1.5 million. Net cash as at 31 December 2018 was £2.1 million.

In addition to increased revenues and reduced EBITDA losses, the Company achieved important commercial milestones to support continued growth:

· Completed two global supply agreements with Nouryon for Itaconix detergent and hair styling polymers;

· Delivered the first purchase order of Itaconix® CHT™ 122 for use in a European non-phosphate automatic dish detergent; and

· Completed the divestment of its legacy nicotine gum business with the sale of its interest in Alkalon A/S for £0.2 million.

With this first half financial performance and commercial progress, the Board believes the Company is currently on track to meet market expectations for the full year.

John R. Shaw, CEO of Itaconix, stated: "Revenues for the first half of 2019 show a growing base of end-product formulations where our polymers are delivering key functional advantages. Use of our polymers in increasingly broader categories of consumer products has established the foundation for many years of revenue growth, especially when combined with the global reach of our partners."

1 Earnings before interest, tax, depreciation and amortisation.

Ends

For further information please contact:

Itaconix

+1 (603) 775 4400

 

John R. Shaw

N+1 Singer

+44 (0) 207 496 3000

Richard Lindley / James Moat (Corporate Finance)

Mia Gardner (Corporate Broking)

 

About Itaconix

Itaconix plc is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDXGDRBGBBGCL
Date   Source Headline
23rd Jun 20205:31 pmRNSLaunch of Fundraise
19th May 20207:00 amRNSNew Loan Funding
5th May 20209:05 amRNSSecond Price Monitoring Extn
5th May 20209:00 amRNSPrice Monitoring Extension
5th May 20207:00 amRNSStrong Revenue Momentum and Extended Funding
17th Mar 20207:00 amRNSCompany Update on Funding and Business Plan
4th Mar 20207:00 amRNSNew Collaboration in Biodegradable Packaging
25th Feb 20207:00 amRNSOrder for Sustainable Detergent Ingredient
20th Feb 20207:00 amRNSHolding(s) in Company
20th Feb 20207:00 amRNSHolding(s) in Company
18th Feb 20202:49 pmRNSHolding(s) in Company
18th Feb 20209:31 amRNSBlock listing Interim Review
12th Feb 20207:15 amRNSNew Supply and License Agreements with New Wave
10th Feb 20207:00 amRNSNew BIO*AsterixT Product Line
28th Jan 20207:00 amRNSIntroduction of New Detergent Polymer
21st Jan 20202:14 pmRNSHolding(s) in Company
17th Jan 20207:00 amRNSTermination of Chelates Agreement
9th Jan 20207:00 amRNSFull Year Trading Update
8th Jan 20207:00 amRNSNew patent issued for detergent compositions
7th Jan 20207:00 amRNSFirst order to Croda for new odour control polymer
18th Dec 20198:00 amRNSCommencement of Trading on US OTCQB Market
24th Oct 20197:00 amRNSExpansion of Croda Supply & Joint Marketing Agrmt
23rd Oct 20197:00 amRNSIntroduction of New Odour Control Product Line
21st Oct 20195:57 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSTrading Update
27th Sep 20197:00 amRNSRecognition from Biofuels Digest
16th Sep 20195:11 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSInterim results
30th Aug 20193:17 pmRNSHolding(s) in Company
30th Aug 20197:00 amRNSAppointment of New Chief Financial Officer
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
20th Aug 20197:00 amRNSHolding(s) in Company
16th Aug 20199:00 amRNSPrice Monitoring Extension
6th Aug 20194:50 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSPDMR Shareholding
2nd Aug 20192:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20192:00 pmRNSPrice Monitoring Extension
2nd Aug 201911:05 amRNSSecond Price Monitoring Extn
2nd Aug 201911:00 amRNSPrice Monitoring Extension
29th Jul 20196:03 pmRNSBlock listing Interim Review
19th Jul 20193:28 pmRNSResult of AGM
17th Jul 20197:00 amRNSHalf-Year Trading Update
10th Jul 20194:41 pmRNSSecond Price Monitoring Extn
10th Jul 20194:35 pmRNSPrice Monitoring Extension
9th Jul 20195:19 pmRNSHolding(s) in Company
27th Jun 20197:00 amRNSPreliminary Results
14th Jun 20197:00 amRNSNotice of Results
29th May 20197:00 amRNSSale of Minority Interest in Alkalon
21st May 20197:00 amRNSFirst personal care purchase order from Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.